The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Vulcan Energy (VUL) signs a term sheet agreement with Germany-based Nobian for a 50/50 joint venture and equity financing for the Vulcan Central Lithium Plant (CLP)
  • VUL will leverage Nobian’s long-standing experience in industrial crystallisation, electrolysis, and operating chloralkali plants for the construction of its CLP
  • VUL Managing Director and CEO Francis Wedin says Nobian’s equity investment will help the company provide secure, sustainable and carbon-neutral lithium chemicals into the European electric vehicle market
  • The CLP SPV2 phase has been pre-valued at €322 million, and Nobian will contribute €161 million (A$265 million) based on this valuation.
  • The agreement is subject to the completion of definitive agreements between the companies, which is expected within ten weeks from the date of the term sheet
  • VUL shares are up 0.35 per cent to $5.75 at 10:32 am AEST

Vulcan Energy (VUL) has signed a term sheet agreement with Germany-based Nobian GmbH to form a 50/50 joint venture and equity financing for the company’s Central Lithium Plant (CLP) in Germany as part of its Zero Carbon Lithium project.

Through the proposed strategic partnership, VUL will be able to take advantage of Nobian’s longstanding experience in industrial crystallisation, electrolysis, and operating chloralkali plants.

Vulcan’s Zero Carbon Lithium project uses chloralkali-type electrolysis cells to produce lithium hydroxide at its CLP. The partnership between Vulcan and Nobian is the result of 15 months of collaboration between the businesses.

“This is a positive step forward as part of our stated strategy to prioritise project-level equity investments for funding of phase one of our Zero Carbon Lithium project,” VUL Managing Director and CEO Francis Wedin said.

Under the agreement, the two companies will form a joint venture special purpose vehicle, dubbed SPV2, as part of Vulcan’s two-phased approach to project financing.

The SPV1 phase includes the plant and infrastructure associated with producing renewable energy and lithium chloride (LiCI) and includes land, wells, pipelines, geothermal testing and lithium extraction plants.

SPV2 envisions the production of the completed CLP, which would convert lithium chloride into lithium hydroxide monohydrate (LHM) with a by-product of hydrogen chloride (HCl).

LHM will then be sold to Vulcan’s parent company, which will distribute the product to VUL off-takers.

The CLP SPV2 phase has been pre-valued at €322 million, and Nobian will contribute €161 million (A$265 million) in cash as equity to fund the capital expenditures of the CLP based on this valuation.

“After 15 months of collaboration, Nobian and Vulcan have developed a very positive
relationship, and we welcome this step towards Nobian’s equity investment into our Central Lithium Plant (CLP) in Germany to assist us with providing secure, sustainable and carbon-neutral lithium chemicals into the European electric vehicle market, helping to enable the transition to fully electrified transport,” Dr Wedin said.

The agreement is subject to the completion of definitive agreements between the companies, which is expected within ten weeks from the date of the term sheet.

VUL shares were up 0.35 per cent to $5.75 at 10:32 am AEST.

VUL by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…